Vimarsana
Biggest News Aggregation in the World

Page 16 - Hartmutj Ehrlich News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hartmutj Ehrlich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hartmutj Ehrlich Today - Breaking & Trending Today

Abivax to present at the 39th Annual J.P. Morgan Healthcare Conference ahead of major clinical miles - Vimarsana News

Abivax to present at the 39th Annual J.P. Morgan Healthcare Conference ahead of major clinical miles

Search jobs 21-Dec-2020 DGAP-News: ABIVAX / Key word(s): Conference 21.12.2020 / 18:30 Abivax to present at the  39 ahead of major clinical milestones PARIS, December 21, 2020 - 6:30 p.m. (CET) - Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, today announced that Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, will present at the 39 th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 at 10:00 am to 1...

Investegate |ABIVAX Announcements | ABIVAX: Abivax to present at the 39th Annual J.P. Morgan Healthcare Conference ahead of major clinical milestones - Vimarsana News

Investegate |ABIVAX Announcements | ABIVAX: Abivax to present at the 39th Annual J.P. Morgan Healthcare Conference ahead of major clinical milestones

ABIVAX DGAP-News: ABIVAX / Key word(s): Conference Abivax to present at the 39th Annual J.P. Morgan Healthcare Conference ahead of major clinical milestones 21.12.2020 / 18:30 Abivax to present at the  39 ahead of major clinical milestones PARIS, December 21, 2020 - 6:30 p.m. (CET) - Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, today announced that Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, will present at the 39 th Annual J.P. Morgan H...